Article
Evaluation of TIB Molbiol LightMix® assays for detection of Mycoplasma genitalium and key resistance mutations for macrolides and fluoroquinolones.
Letters in applied microbiology - 1 Nov 2023
Balgovind Prisha, Atchison Steph, Danielewski Jennifer, Garland Suzanne M, Costa Anna-Maria, Bodiyabadu Kaveesha, Murray Gerald L
Abstract excerpt
The LightMix® Modular Mycoplasma Macrolide and LightMix® Modular parC Fluoroquinolone Resistance assays (TIB Molbiol) were evaluated using sequential Mycoplasma genitalium positive (n = 125) and negative (n = 93) clinical samples. Results were compared to the results of an established commercial assay (ResistancePlus MG assay, SpeeDx Pty Ltd) or Sanger sequencing (for parC). Detection of M. genitalium by the TIB...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
